quantit
multiplex
realtim
rtpcr
assay
util
fluoresc
reson
energi
transfer
fret
hybrid
probe
develop
detect
respiratori
virus
includ
well
recogn
viral
caus
respiratori
syncyti
viru
influenza
virus
b
parainfluenza
virus
type
adenoviru
well
virus
describ
recent
caus
acut
respiratori
tract
infect
human
coronavirus
human
bocaviru
human
metapneumoviru
fret
probe
improv
toler
singl
base
mismatch
probe
chemistri
reduc
chanc
miss
highli
variabl
rna
virus
assay
could
detect
dnarna
copiesl
copiesml
valid
known
posit
respiratori
specimen
indic
similar
specif
commerci
direct
immunofluoresc
assay
ifa
singleround
pcr
use
initi
identif
screen
ifa
neg
respiratori
specimen
identifi
new
virus
case
addit
well
recogn
virus
miss
routin
diagnost
assay
includ
coinfect
virus
could
detect
clinic
screen
panel
assay
demonstr
improv
sensit
scope
detect
respiratori
virus
rel
routin
antigen
detect
assay
quantit
util
may
facilit
investig
role
coinfect
viral
load
respiratori
viru
pathogenesi
acut
respiratori
tract
infect
lead
caus
paediatr
morbid
mortal
murray
et
al
well
recogn
viral
agent
tradit
associ
respiratori
tract
infect
respiratori
syncyti
viru
rsv
influenza
virus
b
parainfluenza
virus
piv
adenovirus
adv
sinc
improv
viru
discoveri
techniqu
seen
identif
sever
new
virus
associ
acut
respiratori
tract
infect
includ
human
metapneumoviru
hmpv
van
den
hoogen
et
al
human
coronavirus
hcov
woo
et
al
van
der
hoek
et
al
human
bocaviru
hbov
alland
et
al
present
commonli
use
techniqu
diagnosi
viral
respiratori
tract
infect
cell
cultur
usual
combin
direct
immunofluoresc
assay
ifa
fischbach
dun
nucleic
acid
detect
method
recent
becom
readili
avail
diagnosi
viru
infect
watzing
et
al
compar
studi
shown
detect
respiratori
virus
realtim
rtpcr
significantli
sensit
convent
detect
method
gharabaghi
et
al
kuyper
et
al
smith
et
al
van
de
pol
et
al
major
realtim
rtpcr
detect
assay
respiratori
virus
qualit
natur
even
though
qualit
realtim
pcr
diagnost
set
numer
advantag
tradit
detect
method
one
limit
discrimin
current
infect
shed
low
concentr
viru
previou
infect
signific
coinfect
also
portray
contrast
quantit
realtim
pcr
provid
qualit
well
quantit
inform
advantag
quantit
realtim
pcr
permit
assess
viral
load
given
time
point
facilit
monitor
respons
treatment
offer
possibl
determin
dynam
viru
prolifer
watzing
et
al
quantit
test
may
aid
studi
viru
pathogenesi
develop
vaccin
antivir
strategi
facilit
investig
import
respiratori
virus
detect
coinfect
patient
qualit
detect
viral
respiratori
pathogen
multiplex
realtim
pcr
describ
previous
brittainlong
et
al
gunson
et
al
templeton
et
al
studi
employ
use
hydrolysi
probe
brittainlong
et
al
gunson
et
al
molecular
beacon
templeton
et
al
probe
chemistri
highli
sensit
hybrid
mismatch
due
high
mutat
frequenc
respiratori
viral
genom
may
result
fals
neg
result
gunson
et
al
contrast
fluoresc
reson
energi
transfer
fret
hybrid
probe
toler
mismatch
zaayman
et
al
addit
probe
hydrolyz
amplif
reaction
therebi
facilit
gener
ampliconspecif
melt
curv
discrimin
incorpor
multipl
target
per
reaction
studi
develop
applic
novel
quantit
realtim
rtpcr
assay
util
fret
probe
differenti
diagnosi
well
recogn
new
respiratori
virus
describ
consist
four
multiplex
reaction
cover
differ
virus
may
run
individu
concurr
tissu
cultur
posit
control
avail
rsv
subtyp
b
piv
influenza
b
adenoviru
clinic
specimen
test
posit
pcr
hmpv
obtain
dr
jan
kimpen
univers
utrecht
netherland
hbov
dr
heidi
smut
univers
cape
town
south
africa
rna
posit
clinic
specimen
obtain
dr
astrid
vabret
univers
hospit
caen
franc
valid
multiplex
assay
respiratori
specimen
previous
test
posit
viru
also
collect
addit
respiratori
specimen
n
test
neg
respiratori
virus
direct
immunofluoresc
light
diagnost
tm
respiratori
panel
viral
screen
identif
kit
rsv
b
piv
influenza
b
adenoviru
millipor
usa
rapid
bd
directigen
tm
rsv
test
bd
franklin
lake
nj
usa
collect
year
depart
medic
virolog
univers
pretorian
health
laboratori
servic
tshwane
academ
divis
specimen
includ
nasopharyng
aspir
bronchoalveolar
lavag
specimen
endotrach
aspir
sputum
specimen
upon
receipt
phosphat
buffer
salin
pb
ad
nasopharyng
aspir
final
volum
ml
vortex
specimen
clarifi
cell
mucu
g
min
supernat
remov
store
c
pcr
analysi
nucleic
acid
cultur
viru
control
extract
l
cell
cultur
fluid
use
high
pure
pcr
templat
kit
roch
mannheim
germani
accord
manufactur
instruct
total
nucleic
acid
clinic
specimen
extract
l
clarifi
nasopharyng
aspir
autom
magna
pure
nucleic
acid
isol
system
roch
mannheim
germani
use
magna
pure
lc
total
nucleic
acid
isol
kit
roch
mannheim
germani
accord
manufactur
instruct
neg
water
control
includ
everi
run
viru
multipl
sequenc
align
known
strain
identifi
blast
search
analysi
perform
clustalx
version
thompson
et
al
conserv
region
identifi
primer
probe
design
primer
design
use
rozen
skaletski
melt
temperatur
c
fret
probe
design
support
tibmol
biolog
berlin
germani
evalu
use
light
cycler
probe
design
softwar
version
site
layout
multiplex
assay
includ
primer
probe
sequenc
indic
tabl
serv
intern
control
refer
gene
multiplex
reaction
dehydrogenas
gapdh
target
separ
primerprob
set
individu
detect
wavelength
nm
cdna
synthes
use
expand
revers
transcriptas
roch
mannheim
germani
accord
manufactur
instruct
realtim
pcr
reaction
perform
use
light
cycler
faststart
dna
master
plu
hybprob
kit
roch
mannheim
germani
contain
l
master
mix
nm
probe
variabl
concentr
primer
indic
tabl
l
cdna
reaction
mixtur
templat
final
volum
l
realtim
pcr
cycl
perform
light
cycler
roch
mannheim
germani
follow
c
min
follow
cycl
c
c
c
c
ramp
rate
cs
c
follow
melt
curv
analysi
c
c
c
ramp
rate
cs
pcr
amplicon
dna
sequenc
gel
purifi
use
wizard
sv
gel
pcr
cleanup
system
promega
madison
wi
usa
accord
manufactur
instruct
dna
sequenc
perform
specif
primer
use
abi
prism
bigdy
termin
cycl
sequenc
reaction
kit
version
abi
prism
dna
sequenc
appli
biosystem
foster
citi
ca
usa
accord
manufactur
instruct
target
region
respect
viru
intern
control
gapdh
amplifi
expand
high
fidel
pcr
kit
roch
mannheim
germani
use
specif
primer
amplicon
gel
purifi
use
wizard
sv
gel
pcr
cleanup
system
promega
madison
wi
usa
clone
clone
vector
fermenta
ontario
canada
accord
manufactur
instruct
vitro
transcript
perform
transcriptaid
tm
high
yield
transcript
kit
fermenta
ontario
canada
accord
manufactur
instruct
plasmid
dna
remov
addit
u
dnase
end
reaction
incub
c
h
rna
purifi
rneasi
plu
mini
kit
qiagen
hamburg
germani
concentr
determin
nanodrop
spectrophotomet
nanodrop
technolog
wilmington
de
usa
nm
detect
limit
multiplex
assay
determin
test
serial
dilut
quantifi
rna
transcript
detect
dilut
perform
triplic
detect
limit
defin
lowest
concentr
three
tabl
design
multiplex
realtim
rtpcr
multiplex
assay
indic
virus
cover
four
multiplex
reaction
well
gene
primer
probe
target
wavelength
detect
nest
pcr
hbov
c
dna
copiesl
one
clinic
specimen
avail
valid
viru
howev
addit
three
piv
posit
specimen
previous
test
neg
routin
immunofluoresc
detect
neg
specimen
screen
b
due
limit
sampl
volum
interassay
coeffici
variat
could
determin
c
specimen
hbov
could
detect
seminest
pcr
replic
could
detect
dna
virus
dilut
seri
plasmid
dna
use
confid
level
data
analys
determin
student
ttest
twotail
distribut
optim
multiplex
assay
done
cultur
control
specimen
previous
test
posit
pcr
independ
laboratori
newli
design
realtim
rtpcr
assay
initi
optim
monospecif
assay
assess
specif
primer
probe
assay
test
crossreact
among
virus
use
control
specimen
viral
load
approxim
copiesml
case
viru
detect
specif
primer
probe
set
crossreact
observ
monospecif
assay
subsequ
combin
form
four
multiplex
assay
compris
follow
virus
multiplex
b
hmpv
hbov
multiplex
viru
piv
multiplex
b
adenoviru
multiplex
virus
combin
variou
multiplex
assay
accord
share
similar
clinic
manifest
suscept
age
group
sensit
assay
determin
triplic
amplif
serial
dilut
vitro
transcrib
rna
clone
control
detect
limit
rna
virus
rang
vitro
transcrib
rna
copiesl
correspond
copiesml
specimen
plasmid
dna
copiesl
dna
virus
correspond
copiesml
specimen
tabl
lower
concentr
detect
howev
concentr
detect
replic
could
achiev
therefor
consid
true
detect
limit
assess
interrun
precis
respect
assay
extract
realtim
rtpcr
detect
perform
triplic
aliquot
viral
suspens
three
independ
realtim
rtpcr
run
perform
show
coeffici
variat
tabl
indic
high
reproduc
realtim
rtpcr
assay
four
multiplex
optim
perform
cycl
condit
simultan
use
event
conserv
region
could
identifi
techniqu
describ
pontkingdon
lyon
use
overcom
techniqu
appli
probe
use
detect
rsv
b
determin
amplif
competit
may
lead
interfer
simultan
quantit
one
viru
singl
reaction
quantifi
control
ad
togeth
vari
concentr
quantifi
concurr
result
indic
simultan
quantit
two
virus
vari
concentr
copiesml
ie
detect
amplif
cycl
show
coeffici
variat
indic
multiplex
assay
accur
quantifi
two
virus
singl
reaction
howev
second
viru
detect
amplif
cycl
ie
viru
concentr
copiesml
third
viru
present
accur
quantit
viral
load
could
achiev
event
virus
quantifi
separ
ensur
accur
quantit
viral
load
howev
diagnost
purpos
simultan
qualit
detect
one
viru
achiev
detect
limit
approxim
copiesml
multiplex
assay
valid
total
clinic
specimen
previous
test
posit
presenc
respiratori
virus
ifa
pcr
seminest
pcr
except
hbov
detect
specimen
virus
detect
known
posit
specimen
evalu
tabl
hbov
previous
identifi
posit
control
specimen
seminest
pcr
specimen
hbov
could
detect
singleround
pcr
detect
limit
bocaviru
realtim
pcr
copiesl
copiesml
specimen
suggest
high
sensit
although
sensit
convent
seminest
pcr
initi
detect
smut
hardi
applic
quantit
featur
assay
demonstr
rsv
posit
specimen
children
mild
diseas
infant
visit
outpati
requir
hospit
children
sever
diseas
patient
admit
intens
care
unit
tabl
associ
higher
viral
load
sever
diseas
tabl
calcul
viral
load
singl
rsv
infect
patient
mild
sever
respiratori
tract
diseas
sever
diseas
n
p
ci
mean
median
rang
addit
respiratori
virus
detect
respiratori
specimen
test
neg
routin
diagnost
assay
demonstr
rsv
viral
load
patient
sever
diseas
significantli
higher
p
mean
copiesml
median
copiesml
compar
patient
mild
diseas
mean
copiesml
copiesml
intern
control
gapdh
continu
detect
supernat
fraction
concentr
rang
copiesml
process
specimen
mean
copiesml
median
copiesml
confirm
valu
nucleic
acid
extract
control
realtim
rtpcr
screen
respiratori
specimen
neg
respiratori
virus
target
routin
ifa
identifi
new
virus
case
well
addit
well
recogn
virus
previous
miss
routin
ifa
tabl
human
bocaviru
n
human
metapneumoviru
n
human
coronaviru
n
detect
ifa
neg
group
although
detect
ifa
neg
specimen
group
detect
coinfect
ifa
posit
control
specimen
coinfect
piv
occur
coinfect
rsv
addit
ifa
neg
specimen
test
posit
virus
alreadi
includ
ifa
panel
suggest
mark
improv
sensit
ifa
rule
possibl
fals
posit
result
onethird
amplicon
randomli
select
sequenc
confirm
specif
assay
sequenc
reaction
success
nonspecif
detect
observ
coinfect
detect
specimen
tabl
viral
load
quantifi
coinfect
occur
hmpv
hbov
coronavirus
tabl
though
clinic
relev
find
describ
elsewher
virus
could
detect
differ
type
respiratori
specimen
nasopharyng
aspir
specimen
bronchoalveolar
lavag
specimen
endotrach
aspir
specimen
sputum
specimen
melt
curv
analysi
rsv
posit
clinic
specimen
reveal
four
distinct
melt
curv
melt
temperatur
c
c
c
c
fig
identifi
rsv
infect
patient
respect
sequenc
rsv
target
region
identifi
presenc
singl
base
mutat
region
probe
hybrid
templat
fig
despit
complet
conserv
specimen
sequenc
genbank
area
confirm
robust
fret
hybrid
probe
technolog
toler
mismatch
overcom
variabl
rna
virus
rsv
cstrain
detect
hospit
patient
wherea
rsv
c
c
cstrain
associ
slightli
higher
hospit
rate
detect
hospit
patient
howev
unlik
singl
base
chang
nucleoprotein
influenc
diseas
sever
though
investig
follow
melt
curv
analysi
reveal
differ
virus
detect
multiplex
assay
combin
respiratori
viru
coinfect
identifi
quantifi
multiplex
realtim
rtpcr
number
detect
quantif
coinfect
copiesml
adv
adv
adv
hbov
adv
hbov
hbov
hmpv
hbov
hmpv
adv
rsv
determin
hbov
hbov
hbov
hbov
hbov
hbov
hmpv
hbov
hmpv
adv
rsv
adv
rsv
adv
rsv
studi
describ
develop
four
quantit
multiplex
realtim
rtpcr
assay
run
concurr
detect
respiratori
virus
detect
respiratori
virus
target
routin
ifa
multiplex
assay
shown
specif
routin
use
commerci
ifa
also
significantli
sensit
increas
detect
virus
inclus
addit
respiratori
virus
detect
assay
increas
overal
detect
frequenc
discrep
result
studi
may
attribut
increas
sensit
realtim
pcr
detect
rsv
previou
studi
report
specimen
posit
pcr
neg
ifa
viral
load
less
copiesml
suggest
lower
limit
sensit
ifa
rang
kuyper
et
al
studi
assay
demonstr
detect
limit
rang
copiesml
log
lower
approxim
ifa
detect
limit
detect
limit
fit
detect
respiratori
virus
previous
report
viral
load
respiratori
specimen
rang
copiesml
kuyper
et
al
viral
load
less
copiesml
describ
though
clinic
relev
low
level
question
alland
et
al
van
der
hoek
et
al
respiratori
specimen
nonhomogen
may
vari
consist
degre
viscos
due
presenc
mucou
volum
manner
collect
thu
make
quantit
analysi
respiratori
specimen
method
difficult
sinc
respiratori
specimen
difficult
standardis
quantit
respiratori
virus
pcr
better
describ
semiquantit
schildgen
et
al
studi
semiquantit
result
rsv
posit
patient
mild
sever
diseas
demonstr
significantli
higher
rsv
viral
load
patient
sever
diseas
confirm
relev
featur
confirm
previou
find
rsv
devincenzo
et
al
fodha
et
al
martin
et
al
continu
detect
intern
control
gapdh
indic
quantit
influenc
poor
rna
extract
pcr
inhibitor
comparison
convent
detect
method
realtim
probe
base
pcr
assay
shown
detect
respiratori
virus
increas
sensit
specif
gharabaghi
et
al
kuyper
et
al
smith
et
al
van
de
pol
et
al
pitfal
realtim
pcr
commonli
use
probe
chemistri
hydrolysi
probe
molecular
beacon
highli
sensit
mismatch
may
lead
fals
neg
result
point
mutat
occur
gunson
et
al
contrast
assay
describ
studi
util
two
fret
hybrid
probe
advantag
abl
toler
greater
number
mismatch
hydrolysi
probe
molecular
beacon
decreas
occurr
fals
neg
result
substanti
benefit
fret
probe
illustr
point
mutat
detect
site
probe
hybrid
target
templat
sever
clinic
specimen
despit
complet
conserv
area
genbank
obstacl
design
fret
hybrid
probe
conserv
area
approxim
nt
need
two
probe
bind
highli
variabl
viru
genom
might
pose
problem
howev
overcom
use
oligonucleotid
probe
complementari
conserv
region
flank
variabl
region
describ
pontkingdon
lyon
bind
probe
bring
two
conserv
region
togeth
result
variabl
region
loop
therebi
omit
variabl
sequenc
conserv
region
could
identifi
case
rsv
piv
techniqu
success
appli
overcom
complic
addit
highli
sensit
specif
assay
turnaround
time
h
cover
virus
test
current
optim
light
cycler
could
transfer
light
cycler
format
paediatr
patient
rapid
diagnosi
respiratori
tract
infect
lead
improv
manag
reduc
unnecessari
antibiot
use
length
hospit
barenfang
et
al
woo
et
al
rapid
diagnosi
also
imper
manag
nosocomi
spread
respiratori
virus
high
risk
patient
eg
bone
marrow
transplant
patient
cancer
recipi
hohenth
et
al
miall
et
al
whimbey
et
al
whimbey
et
al
addit
quantit
applic
assay
contribut
address
question
viral
pathogenesi
may
facilit
investig
import
hmpv
hbov
coronavirus
detect
coinfect
patient
conclus
find
studi
demonstr
applic
multiplex
realtim
pcr
assay
fret
hybrid
probe
detect
respiratori
virus
associ
viral
load
assay
may
facilit
studi
viru
pathogenesi
facilit
investig
import
respiratori
virus
recent
identifi
caus
acut
respiratori
tract
infect
also
confirm
relev
posit
pcr
find
acut
diseas
